83 POSTER A robust and quantitative biomarker assay for SB939, a potent, orally-active HDAC inhibitor

V. Novotny-Diermayr, V.M. Nayagam, H.H. Hentze, A.L. Liang, Y.K. Loh, N. Sausgruber, P. Yeo, K. Ethirajulu, J.M. Wood
  • European Journal of Cancer Supplements, October 2008, Elsevier
  • DOI: 10.1016/s1359-6349(08)72015-9

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr veronica diermayr